WPD Pharmaceuticals Inc. announced that Dr. Waldemar Debinski, inventor of WPD101, WPD102 and WPD103 drug candidates has joined its Scientific Advisory Board. The Company’s name comes from the names of inventors Dr. Waldemar Priebe and Dr. Waldemar Debinski, which creates the “WPD” in WPD Pharmaceuticals. Waldemar Debinski, MD, PhD, is the Tom and Laura Hearn Professor for the Brain Tumor Center of Excellence and Director of the Brain Tumor Center of Excellence, Wake Forest Baptist Medical Center Comprehensive Cancer Center, and professor of cancer biology, radiation oncology, Microbiology and immunology, and Translational Science Institute at Wake Forest School of Medicine.